Covid-19 roundup: AstraZeneca may not file its vaccine in the US; Ivermectin fails to reduce hospitalizations in large trial

Zachary Brennan

Senior Editor

AstraZeneca’s top researcher Mene Pangalos signaled that the company may cut away from submitting its Covid-19 vaccine to the US FDA for approval, citing months …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: AstraZeneca may not file its vaccine in the US; Ivermectin fails to reduce hospitalizations in large trial

Zachary Brennan

Senior Editor

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

Exclusive: Influential Democrat will oppose Biosecure Act ahead of House vote

Astellas CEO talks future beyond Xtandi as Japanese drugmaker puts roots in Boston

BridgeBio sticks to script for ATTR-CM as Alnylam cleans up ‘typo’ snafu

Roche's Spark loses CEO to RNA upstart; Ex-Elevation Oncology chief takes over at Affimed

Lilly inks obesity deal with seed-stage RNA startup as its genetic medicines effort enters the spotlight

How to secure full enrollment and a 30x ROI: A conversation with the CEO of the boutique enrollment agency doing just ...

Covid-19 roundup: As­traZeneca may not file its vac­cine in the US; Iver­mectin fails to re­duce hos­pi­tal­iza­tions in large tri­al

Senior Editor

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Covid-19 roundup: AstraZeneca may not file its vaccine in the US; Ivermectin fails to reduce hospitalizations in large trial